{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/10/3341836/29489/en/aim-immunotech-reports-second-quarter-2026-financial-results-and-highlights-significant-operational-execution-advancing-ampligen-toward-planned-phase-3-development-in-pancreatic-ca.html", "message": "News view counter 872145 successfully enlarged"}